(NASDAQ:MRGE) announced the earnings results for Fiscal Year 2014 and Quarter 4. The results came in during pre-market on February 26,2015. Company reported revenue of $53.60 Million, below the estimates of $56.34 Million. The revenues were $-2.74 Million or 4.86% below the estimates. Earnings per share were $0.05.The reported EPS was above estimates by $0.01 or 25 %. Analysts had estimated an EPS of $0.04.
Shares of Merge Healthcare Incorporated. (NASDAQ:MRGE) ended the trading session higher after solid profit booking was seen in the counter during day trade. The trading commenced with the first trade executed at $4.28 and concluded with a gain of 0.32 points or 7.67% at $4.49. Intraday, some money was taken off the table which saw the price dip to $4.21. The volume at the end of the trading session was 1,899,024 shares. The 52-week high of the shares is $4.73 and the 52-week low is $1.97. The market cap of the company is $442 million and there are 98,457,000 shares in public circulation.
Merge Healthcare Incorporated. (NASDAQ:MRGE) shares are expected to touch $5 in the short term. This short term price target has been shared by 1 analysts. However, the standard deviation of short term price estimate has been valued at 0. The target price could hit $5 on the higher end and $5 on the lower end.
Merge Healthcare Incorporated (Merge) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the challenges in health information exchange, such as the incorporation of medical images and diagnostic information into broader health information technology (IT) applications and the interoperability of software solutions. It provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials; software for financial and pre-surgical management, and applications that fuel some of the modality vendors worldwide. It provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials; software for financial and pre-surgical management, and applications. On August 4, 2011, it acquired Ophthalmic Imaging Systems (OIS).
